{"nct_id":"NCT02755597","title":"A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2016-07-11","start_date_type":"ACTUAL","primary_completion_date":"2021-03-15","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}